Latest News & Features
Americas
Although recent Federal Circuit decisions on the ‘patent dance’ provide some clarity, the BPCIA still presents difficult and hotly debated issues of interpretation. Stacie Ropka, William Rose and Ryan Hersh of Axinn, Veltrop & Harkrider report. 23 August 2016
Big Pharma
Gilead Sciences has received marketing authorisation from the European Commission for its drug Truvada. 23 August 2016
Americas
AstraZeneca and Eli Lilly have received US Food and Drug Administration fast track designation for the development of a treatment for Alzheimer’s. 23 August 2016
Americas
Pfizer has unveiled plans to acquire US based biopharmaceutical company Medivation for approximately $14 billion. 22 August 2016
Americas
BioLytical Laboratories, a Canadian based biotech company, has filed two patent applications covering a method for detecting the Zika virus. 22 August 2016
Americas
Horizon Pharma has sued Actavis for allegedly infringing four of its patents. 19 August 2016
Americas
Bayer has launched a partnership with CRISPR Therapeutics. 19 August 2016
Americas
The US District Court for the District of Massachusetts has issued a ruling on a summary judgment motion filed by Celltrion Healthcare and Hospira, invalidating a Janssen patent related to Remicade. 18 August 2016
Big Pharma
Teva announced today that the European Commission has granted marketing authorisation for Cinqaero following an efficacy probe. 18 August 2016
Americas
The US Supreme Court’s Mayo and Myriad decisions have brought challenges to subject matter eligibility to the forefront in the biomedical industry, but they do not signal the end of biomedical patents. Pat Carson and Mira Atanassova Mulvaney of Kirkland & Ellis report. 18 August 2016